Illinois-based FutureCeuticals, Inc. announced the appointment of Dr. Nagendra Rangavajla as the Chief Science Officer (CSO).
In this role, Nagendra will use his vast knowledge of the industry and technical expertise to lead the Research and Development (R&D) team in envisioning, evaluating and setting scientific priorities, organizing the scientific team and capabilities, coordinating communication and providing the administrative structure that supports the scientific team.
Nagendra brings more than 20 years of experience in industry with the most recent role of VP of R&D at PanTheryx. Prior to that, Nagendra held global R&D leadership roles at Abbott Nutrition and served in leadership positions at Mead Johnson and Nestle.
“We are excited about what Nagendra brings to us from the CPG industry, but he also shares what I believe is our core passion for advancing health by translating business strategies into R&D pipelines that drive differentiation and value to the business,” says Jeff Van Drunen, President of FutureCeuticals, Inc.